Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Journal of Neuroimmunology|November 21, 2017
Neurodegenerative diseases: The immunological perspectiveMonica Molteni, Carlo RossettiMediators of Inflammation|June 14, 2016
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationMonica Molteni, Sabrina Gemma, Carlo RossettiToxins|July 18, 2018
The Effect of Cyanobacterial LPS Antagonist (CyP) on Cytokines and Micro-RNA Expression Induced by <i>Porphyromonas gingivalis</i> LPSMonica Molteni, Annalisa Bosi, Carlo RossettiTumori|August 8, 2007
Colorectal cancer: what has changed in diagnosis and treatment over the last 50 years?Leandro Gennari, Antonio Russo, Carlo RossettiInternational Journal of Inflammation|April 25, 2018
Natural Products with Toll-Like Receptor 4 Antagonist ActivityMonica Molteni, Annalisa Bosi, Carlo RossettiDialogues in Clinical Neuroscience|October 23, 2019
Drug discovery in psychopharmacology: from 2D models to cerebral organoids
Andrea Carlo Rossetti, Philipp Koch, Julia LadewigCancer Letters|June 1, 2005
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4Monica Molteni, Deborah Marabella, Chiara Orlandi, et al.Scientific Reports|July 29, 2018
MiR-146a induction by cyanobacterial lipopolysaccharide antagonist (CyP) mediates endotoxin cross-toleranceMonica Molteni, Annalisa Bosi, Vincenzo Saturni, et al.Applied and Environmental Microbiology|December 9, 2003
Effects of saxitoxin (STX) and veratridine on bacterial Na+ -K+ fluxes: a prokaryote-based STX bioassayFrancesco Pomati, Carlo Rossetti, Davide Calamari, et al.Epilepsia|October 5, 2011
Therapeutic potential of new antiinflammatory drugsAnnamaria Vezzani, Tamas Bartfai, Marco Bianchi, et al.Pageof 4